Full Text
Cost-effectiveness of adalimumab for the treatment of moderately to severely active ulcerative colitis in Canada

Abstract

Authors

S. Ghosh O. Desjardins M. Skup S. Wang M. Yang H. Yang C. Qi Y. Bao J. Chao

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×